Literature DB >> 9445325

Risk factors for ischemic stroke in a Russian community: a population-based case-control study.

V L Feigin1, D O Wiebers, Y P Nikitin, W M O'Fallon, J P Whisnant.   

Abstract

BACKGROUND AND
PURPOSE: This study was conducted to determine the risk factors for ischemic stroke in a defined Russian population.
METHODS: Our data are based on a population-based case-control study of 237 patients with first-ever ischemic stroke and 237 age- and sex-matched controls. Logistic regression methods for matched pairs were used to estimate the relative risk for the variables studied.
RESULTS: In a multivariate analysis, hypertension, left ventricular hypertrophy on electrocardiography, ischemic heart disease, mitral valve disease, current cigarette smoking, and high body mass index were significant and independent risk factors for ischemic stroke in this Russian community.
CONCLUSIONS: The significant risk factors for ischemic stroke in Novosibirsk are similar to those from other populations and cohorts. This study, the first of stroke risk factors in Russia, has implications for clinical practice and the planning of stroke prevention in the population.

Entities:  

Mesh:

Year:  1998        PMID: 9445325     DOI: 10.1161/01.str.29.1.34

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

1.  A Polymorphism Within the 3'UTR of NLRP3 is Associated with Susceptibility for Ischemic Stroke in Chinese Population.

Authors:  Zhansheng Zhu; Jing Yan; Chunsong Geng; Dagang Wang; Chaoyang Li; Shuai Feng; Huiping Wang
Journal:  Cell Mol Neurobiol       Date:  2015-12-21       Impact factor: 5.046

2.  Left ventricular hypertrophy and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe.

Authors:  M L Bots; Y Nikitin; J T Salonen; P C Elwood; S Malyutina; A Freire de Concalves; J Sivenius; A Di Carlo; P Lagiou; J Tuomilehto; P J Koudstaal; D E Grobbee
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

3.  Association of transforming growth factor-β1 gene C509T, G800A and T869C polymorphisms with intracerebral hemorrhage in North Indian Population: a case-control study.

Authors:  Pradeep Kumar; Amit Kumar; Shubham Misra; Ram Sagar; Mohammad Farooq; Renu Kumari; Subiah Vivekanandhan; Achal Kumar Srivastava; Kameshwar Prasad
Journal:  Neurol Sci       Date:  2015-11-30       Impact factor: 3.307

4.  Tumor necrosis factor-alpha (- 308G/A, + 488G/A, - 857C/T and -1031 T/C) gene polymorphisms and risk of ischemic stroke in north Indian population: A hospital based case-control study.

Authors:  Pradeep Kumar; Amit Kumar; Shubham Misra; Ram Sagar; Mohammad Faruq; Varun Suroliya; Subiah Vivekanandhan; Achal Kumar Srivastava; Kameshwar Prasad
Journal:  Meta Gene       Date:  2015-11-17

5.  Impact of stroke etiology on clinical symptoms and functional status.

Authors:  Ozge Gulsum Memetoglu; Aslihan Taraktas; Naciye Bilgin Badur; Feyza Unlu Ozkan
Journal:  North Clin Istanb       Date:  2014-12-08

6.  Assessment of demographic and clinical characteristics on functional status and disability of patients with stroke.

Authors:  Derya Memis; Erkan Kozanoglu; Bayram Kelle; Mustafa K Goncu
Journal:  Neurosciences (Riyadh)       Date:  2016-10       Impact factor: 0.906

7.  Study of the involved vascular territories in patients with ischemic stroke in Kerman, Iran.

Authors:  Hossein Ali Ebrahimi; Mohammad Saba; Behnaz Sedighi; Hoda Kamali
Journal:  ARYA Atheroscler       Date:  2016-09

8.  Smoking as a crucial independent determinant of stroke.

Authors:  Seana L Paul; Amanda G Thrift; Geoffrey A Donnan
Journal:  Tob Induc Dis       Date:  2004-06-15       Impact factor: 2.600

9.  Identification of genetic contribution to ischemic stroke by screening of single nucleotide polymorphisms in stroke patients by using a case control study design.

Authors:  Amit Kumar; Ram Sagar; Pradeep Kumar; Jitendra K Sahu; Ashoo Grover; Achal K Srivastava; S Vivekanandhan; Kameshwar Prasad
Journal:  BMC Neurol       Date:  2013-10-03       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.